Literature DB >> 14558118

Correlation between the occurrence of 1H-MRS lipid signal, necrosis and lipid droplets during C6 rat glioma development.

Sonja Zoula1, Gwénaël Hérigault, Anne Ziegler, Régine Farion, Michel Décorps, Chantal Rémy.   

Abstract

The aim of this study was to investigate the possible correlation between the 1H MRS mobile lipid signal, necrosis and lipid droplets in C6 rat glioma. First, the occurrence of necrosis and lipid droplets was determined during tumor development, by a histological analysis performed on 34 rats. Neither necrosis nor lipid droplets were observed before 18 days post-implantation. At later stages of development, both necrosis and lipid droplets were apparent, the lipid droplets being mainly located within the necrotic areas. Using a second group of eight rats, a temporal correlation was evidenced between mobile lipid signal detected by in vivo single-voxel one- (136 ms echo time) and two-dimensional J-resolved 1H MR spectroscopy, and the presence of necrosis and lipid droplets on the histological sections obtained from the brains of the same rats. Finally, spatial distribution of the mobile lipid signal was analyzed by chemical-shift imaging performed on a third group of eight animals, at the end of the tumor growth. The spectroscopic image corresponding to the resonance of mobile lipids had its maximum intensity in the center of the tumor where necrotic regions were observed on the histological sections. These necrotic areas contained large amounts of lipid droplets. All these results suggest that mobile lipids detected in vivo by 1H MRS (136 ms echo time) in C6 rat brain glioma arise mainly from lipid droplets located in necrosis. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14558118     DOI: 10.1002/nbm.831

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  24 in total

1.  Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.

Authors:  Yana K Reshetnyak; Lan Yao; Sida Zheng; Sergey Kuznetsov; Donald M Engelman; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

2.  Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Domenico Catapano; Giuseppe M Giannatempo; Simona Bonavita; Maurizio Portaluri; Michela Tosetti; Vincenzo A d'Angelo; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

Review 3.  Interrogating Metabolism in Brain Cancer.

Authors:  Travis C Salzillo; Jingzhe Hu; Linda Nguyen; Nicholas Whiting; Jaehyuk Lee; Joseph Weygand; Prasanta Dutta; Shivanand Pudakalakatti; Niki Zacharias Millward; Seth T Gammon; Frederick F Lang; Amy B Heimberger; Pratip K Bhattacharya
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-11       Impact factor: 2.266

4.  OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.

Authors:  Patricia Coutinho de Souza; Krithika Balasubramanian; Charity Njoku; Natalyia Smith; David L Gillespie; Andrea Schwager; Osama Abdullah; Jerry W Ritchey; Kar-Ming Fung; Debra Saunders; Randy L Jensen; Rheal A Towner
Journal:  J Magn Reson Imaging       Date:  2015-04-29       Impact factor: 4.813

5.  Prognostic factor from MR spectroscopy in rat with astrocytic tumour during radiation therapy.

Authors:  T G Yu; Y Feng; X Y Feng; J Z Dai; H J Qian; Z Huang
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

6.  Proton magnetic resonance spectroscopy in childhood brainstem lesions.

Authors:  L Porto; E Hattingen; U Pilatus; M Kieslich; B Yan; D Schwabe; F E Zanella; H Lanfermann
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

Review 7.  MR-visible lipids and the tumor microenvironment.

Authors:  E James Delikatny; Sanjeev Chawla; Daniel-Joseph Leung; Harish Poptani
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

8.  An iron-based T1 contrast agent made of iron-phosphate complexes: in vitro and in vivo studies.

Authors:  Elisenda Rodríguez; Rui V Simoes; Anna Roig; Elies Molins; Nataliya Nedelko; Anna Slawska-Waniewska; Silvio Aime; Carles Arús; Miquel E Cabañas; Coral Sanfeliu; Sebastián Cerdán; Maria Luisa García-Martín
Journal:  MAGMA       Date:  2007-02-01       Impact factor: 2.310

9.  Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma.

Authors:  Dimpy Koul; Ruijun Shen; Yong-Wan Kim; Yasuko Kondo; Yiling Lu; Jim Bankson; Sabrina M Ronen; D Lynn Kirkpatrick; Garth Powis; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2010-02-15       Impact factor: 12.300

10.  Taurine: a potential marker of apoptosis in gliomas.

Authors:  K S Opstad; B A Bell; J R Griffiths; F A Howe
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.